Cargando…

Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement

OBJECTIVE: The objective of this study was to assess imaging predictors of mitral regurgitation (MR) improvement and to evaluate the impact of MR regression on long-term outcome in patients undergoing transcatheter aortic valve replacement (TAVR). BACKGROUND: Concomitant MR is a frequent finding in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauri, Victor, Körber, Maria I., Kuhn, Elmar, Schmidt, Tobias, Frerker, Christian, Wahlers, Thorsten, Rudolph, Tanja K., Baldus, Stephan, Adam, Matti, ten Freyhaus, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515951/
https://www.ncbi.nlm.nih.gov/pubmed/32072263
http://dx.doi.org/10.1007/s00392-020-01618-9
_version_ 1783586909650419712
author Mauri, Victor
Körber, Maria I.
Kuhn, Elmar
Schmidt, Tobias
Frerker, Christian
Wahlers, Thorsten
Rudolph, Tanja K.
Baldus, Stephan
Adam, Matti
ten Freyhaus, Henrik
author_facet Mauri, Victor
Körber, Maria I.
Kuhn, Elmar
Schmidt, Tobias
Frerker, Christian
Wahlers, Thorsten
Rudolph, Tanja K.
Baldus, Stephan
Adam, Matti
ten Freyhaus, Henrik
author_sort Mauri, Victor
collection PubMed
description OBJECTIVE: The objective of this study was to assess imaging predictors of mitral regurgitation (MR) improvement and to evaluate the impact of MR regression on long-term outcome in patients undergoing transcatheter aortic valve replacement (TAVR). BACKGROUND: Concomitant MR is a frequent finding in patients with severe aortic stenosis but usually left untreated at the time of TAVR. METHODS: Mitral regurgitation was graded by transthoracic echocardiography before and after TAVR in 677 consecutive patients with severe aortic stenosis. 2-year mortality was related to the degree of baseline and discharge MR. Morphological echo analysis was performed to determine predictors of MR improvement. RESULTS: 15.2% of patients presented with baseline MR ≥ 3 +, which was associated with a significantly decreased 2-year survival (57.7% vs. 74.4%, P < 0.001). MR improved in 50% of patients following TAVR, with 44% regressing to MR ≤ 2 +. MR improvement to ≤ 2 + was associated with significantly better survival compared to patients with persistent MR ≥ 3 +. Baseline parameters including non-severe baseline MR, the extent of mitral annular calcification and large annular dimension (≥ 32 mm) predicted the likelihood of an improvement to MR ≤ 2 +. A score based on these parameters selected groups with differing probability of MR ≤ 2 + post TAVR ranging from 10.5 to 94.4% (AUC 0.816; P < 0.001), and was predictive for 2-year mortality. CONCLUSION: Unresolved severe MR is a critical determinant of long term mortality following TAVR. Persistence of severe MR following TAVR can be predicted using selected parameters derived from TTE-imaging. These data call for close follow up and additional mitral valve treatment in this subgroup. GRAPHIC ABSTRACT: Factors associated with MR persistence or regression after TAVR [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00392-020-01618-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7515951
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-75159512020-10-07 Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement Mauri, Victor Körber, Maria I. Kuhn, Elmar Schmidt, Tobias Frerker, Christian Wahlers, Thorsten Rudolph, Tanja K. Baldus, Stephan Adam, Matti ten Freyhaus, Henrik Clin Res Cardiol Original Paper OBJECTIVE: The objective of this study was to assess imaging predictors of mitral regurgitation (MR) improvement and to evaluate the impact of MR regression on long-term outcome in patients undergoing transcatheter aortic valve replacement (TAVR). BACKGROUND: Concomitant MR is a frequent finding in patients with severe aortic stenosis but usually left untreated at the time of TAVR. METHODS: Mitral regurgitation was graded by transthoracic echocardiography before and after TAVR in 677 consecutive patients with severe aortic stenosis. 2-year mortality was related to the degree of baseline and discharge MR. Morphological echo analysis was performed to determine predictors of MR improvement. RESULTS: 15.2% of patients presented with baseline MR ≥ 3 +, which was associated with a significantly decreased 2-year survival (57.7% vs. 74.4%, P < 0.001). MR improved in 50% of patients following TAVR, with 44% regressing to MR ≤ 2 +. MR improvement to ≤ 2 + was associated with significantly better survival compared to patients with persistent MR ≥ 3 +. Baseline parameters including non-severe baseline MR, the extent of mitral annular calcification and large annular dimension (≥ 32 mm) predicted the likelihood of an improvement to MR ≤ 2 +. A score based on these parameters selected groups with differing probability of MR ≤ 2 + post TAVR ranging from 10.5 to 94.4% (AUC 0.816; P < 0.001), and was predictive for 2-year mortality. CONCLUSION: Unresolved severe MR is a critical determinant of long term mortality following TAVR. Persistence of severe MR following TAVR can be predicted using selected parameters derived from TTE-imaging. These data call for close follow up and additional mitral valve treatment in this subgroup. GRAPHIC ABSTRACT: Factors associated with MR persistence or regression after TAVR [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00392-020-01618-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-02-18 2020 /pmc/articles/PMC7515951/ /pubmed/32072263 http://dx.doi.org/10.1007/s00392-020-01618-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Mauri, Victor
Körber, Maria I.
Kuhn, Elmar
Schmidt, Tobias
Frerker, Christian
Wahlers, Thorsten
Rudolph, Tanja K.
Baldus, Stephan
Adam, Matti
ten Freyhaus, Henrik
Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
title Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
title_full Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
title_fullStr Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
title_full_unstemmed Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
title_short Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
title_sort prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515951/
https://www.ncbi.nlm.nih.gov/pubmed/32072263
http://dx.doi.org/10.1007/s00392-020-01618-9
work_keys_str_mv AT maurivictor prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT korbermariai prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT kuhnelmar prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT schmidttobias prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT frerkerchristian prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT wahlersthorsten prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT rudolphtanjak prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT baldusstephan prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT adammatti prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement
AT tenfreyhaushenrik prognosisofpersistentmitralregurgitationinpatientsundergoingtranscatheteraorticvalvereplacement